Accessibility Menu
 
Pro-Dex logo

Pro-Dex

(NASDAQ) PDEX

Current Price$51.31
Market Cap$157.48M
Since IPO (1992)+803%
5 Year+81%
1 Year-1%
1 Month+11%

Pro-Dex Financials at a Glance

Market Cap

$157.48M

Revenue (TTM)

$72.10M

Net Income (TTM)

$11.34M

EPS (TTM)

$3.40

P/E Ratio

14.44

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$51.31

Volume

1,428

Open

$48.57

Previous Close

$51.31

Daily Range

$48.57 - $52.24

52-Week Range

$23.47 - $70.26

PDEX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pro-Dex

Industry

Healthcare Equipment and Supplies

Employees

181

CEO

Richard Lee van Kirk, Jr., MBA

Headquarters

Irvine, CA 92614, US

PDEX Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

16%

Net Income Margin

16%

Return on Equity

31%

Return on Capital

23%

Return on Assets

18%

Earnings Yield

6.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$157.48M

Shares Outstanding

3.21M

Volume

1.43K

Short Interest

0.00%

Avg. Volume

26.42K

Financials (TTM)

Gross Profit

$19.51M

Operating Income

$10.69M

EBITDA

$14.13M

Operating Cash Flow

$1.68M

Capital Expenditure

$1.25M

Free Cash Flow

$2.93M

Cash & ST Invst.

$7.16M

Total Debt

$16.58M

Pro-Dex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$18.66M

+11.1%

Gross Profit

$5.74M

+13.2%

Gross Margin

30.77%

N/A

Market Cap

$157.48M

N/A

Market Cap/Employee

$1.08M

N/A

Employees

146

N/A

Net Income

$2.19M

+7.2%

EBITDA

$3.38M

+9.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$3.02M

+76.9%

Accounts Receivable

$18.15M

-1.7%

Inventory

$21.71M

+10.7%

Long Term Debt

$8.84M

-22.5%

Short Term Debt

$2.99M

-53.2%

Return on Assets

18.21%

N/A

Return on Invested Capital

22.68%

N/A

Free Cash Flow

$3.50M

+174.6%

Operating Cash Flow

$3.57M

+186.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
APYXApyx Medical Corporation
$3.63-1.63%
LUCDLucid Diagnostics Inc.
$1.15+0.00%
MBOTMicrobot Medical Inc.
$2.37-1.66%
RPIDRapid Micro Biosystems, Inc.
$2.16-4.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About PDEX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.